NVRO - Nevro Corp Stock Price, Fair Value and News

9.75USD-0.13 (-1.32%)Market Closed

Market Summary

USD9.75-0.13

Market Closed

-1.32%

NVRO Stock Price

View Fullscreen

NVRO RSI Chart

NVRO Valuation

Market Cap

358.1M

Price/Earnings (Trailing)

-4.34

Price/Sales (Trailing)

0.83

EV/EBITDA

-7.1

Price/Free Cashflow

-5.05

NVRO Price/Sales (Trailing)

NVRO Profitability

Operating Margin

76.19%

EBT Margin

-20.47%

Return on Equity

-29.65%

Return on Assets

-13.86%

Free Cashflow Yield

-19.82%

NVRO Fundamentals

NVRO Revenue

Revenue (TTM)

430.7M

Rev. Growth (Yr)

5.78%

Rev. Growth (Qtr)

-12.29%

NVRO Earnings

Earnings (TTM)

-82.6M

Earnings Growth (Yr)

27.46%

Earnings Growth (Qtr)

-182.92%

Breaking Down NVRO Revenue

Last 7 days

4.2%

Last 30 days

24.0%

Last 90 days

-12.8%

Trailing 12 Months

-60.4%

How does NVRO drawdown profile look like?

NVRO Financial Health

Current Ratio

7.38

Debt/Equity

0.77

Debt/Cashflow

-0.29

NVRO Investor Care

Shares Dilution (1Y)

2.54%

Diluted EPS (TTM)

-2.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	430.7M	0	0	0
2023	414.9M	419.4M	422.8M	425.2M
2022	386.1M	388.0M	395.3M	406.4M
2021	363.2M	409.1M	393.9M	386.9M
2020	395.6M	358.4M	366.7M	362.0M
2019	381.8M	379.3M	383.8M	390.3M
2018	345.9M	363.9M	377.3M	387.3M
2017	255.3M	277.9M	299.2M	326.7M
2016	101.6M	145.6M	191.1M	228.5M
2015	35.6M	39.5M	46.2M	69.6M
2014	24.8M	26.6M	29.1M	32.6M
2013	19.5M	20.8M	22.2M	23.5M
2012	0	0	0	18.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

CEO	Mr. Kevin R. Thornal
WEBSITE	https://nevro.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1087

Nevro Corp Frequently Asked Questions

What is the ticker symbol for Nevro Corp? What does NVRO stand for in stocks?

NVRO is the stock ticker symbol of Nevro Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nevro Corp (NVRO)?

As of Thu Jul 25 2024, market cap of Nevro Corp is 362.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVRO stock?

You can check NVRO's fair value in chart for subscribers.

Is Nevro Corp a good stock to buy?

The fair value guage provides a quick view whether NVRO is over valued or under valued. Whether Nevro Corp is cheap or expensive depends on the assumptions which impact Nevro Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVRO.

What is Nevro Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, NVRO's PE ratio (Price to Earnings) is -4.39 and Price to Sales (PS) ratio is 0.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVRO PE ratio will change depending on the future growth rate expectations of investors.